ANNEXON, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANNEXON, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $564.00K.
- ANNEXON, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $229.00K, a 269.35% increase year-over-year.
- ANNEXON, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $3.00K, a 99.43% decline year-over-year.
- ANNEXON, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $62.00K, a 71.43% decline year-over-year.
- ANNEXON, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $461.00K, a 62.58% decline from fiscal 2024.
- ANNEXON, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $1.23M, a 749.66% increase from fiscal 2023.
- ANNEXON, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $145.00K, a 81.25% increase from fiscal 2022.
- ANNEXON, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $80.00K, a 95.03% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $564.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $229.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $461.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $62.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.23M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $530.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $171.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $217.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $145.00K 10-K · filed 2025-03-03 | |
| 2023-03-31 | $111.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $80.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $45.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $19.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $1.61M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $322.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $534.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $268.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $22.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $22.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $3.00K 10-K · filed 2021-03-25 | |
| 2019-03-31 | $3.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |